latest news

latest news

Find out what’s new at Alternate Health.

CANADIAN CANNABIS BUYS U.S. PHARMA

May 9, 2019
TORONTO – May 9, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF) an international leader in technology and extraction solutions for the regulated CBD industry, announced today a key step forward in the Company’s pharmaceutical-grade CBD product manufacturing strategy, having signed a joint venture agreement with Oltecate Enterprises (“Oltecate”), a COFEPRIS-licensed Mexican CBD distributor, with an eye for expansion throughout Latin America.

read more

ALTERNATE HEALTH TARGETS CBD INDUSTRY WITH US$20 MILLION BLAINE LABS ACQUISITION

May 2, 2019
TORONTO – May 2, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in technology solutions for the regulated CBD industry, announced today that the Company is entering the CBD-infused product market following an agreement to acquire Blaine Labs Inc., a leading manufacturer and distributor of FDA-approved and cGMP-certified dermatological products, with over 50 SKUs currently available in major retailers, including Walmart, Amazon, CVS and Walgreens.

read more

Find out what’s new at Alternate Health.

CANADIAN CANNABIS BUYS U.S. PHARMA

May 9, 2019
TORONTO – May 9, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF) an international leader in technology and extraction solutions for the regulated CBD industry, announced today a key step forward in the Company’s pharmaceutical-grade CBD product manufacturing strategy, having signed a joint venture agreement with Oltecate Enterprises (“Oltecate”), a COFEPRIS-licensed Mexican CBD distributor, with an eye for expansion throughout Latin America.

read more

ALTERNATE HEALTH TARGETS CBD INDUSTRY WITH US$20 MILLION BLAINE LABS ACQUISITION

May 2, 2019
TORONTO – May 2, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in technology solutions for the regulated CBD industry, announced today that the Company is entering the CBD-infused product market following an agreement to acquire Blaine Labs Inc., a leading manufacturer and distributor of FDA-approved and cGMP-certified dermatological products, with over 50 SKUs currently available in major retailers, including Walmart, Amazon, CVS and Walgreens.

read more